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Abstract
Background The megalin/cubilin/amnionless complex is es-
sential for albumin and low molecular weight (LMW) protein
reabsorption by renal proximal tubules (PT). Mutations of the
LRP2 gene encoding megalin cause autosomal recessive
Donnai–Barrow/facio-oculo-acoustico-renal syndrome (DB/
FOAR), which is characterized by LMW proteinuria. The
pathophysiology of DB/FOAR-associated PT dysfunction re-
mains unclear.
Clinical case A 3-year-old girl presented with growth retar-
dation and proteinuria. Clinical examination was unremark-
able, except for a still-opened anterior fontanel and myopia.
Psychomotor development was delayed. At 6, she developed
sensorineural hearing loss. Hypertelorismwas noted when she
turned 12. Blood analyses, including renal function parame-
ters, were normal. Urine sediment was bland. Proteinuria was
significant and included albumin and LMW proteins. Immu-
noblotting analyses detected cubilin and type 3 carbonic
anhydrase (CA3) in the urine. Renal ultrasound was unre-
markable. Optical examination of a renal biopsy did not
disclose any tubular or glomerular abnormality. Electron mi-
croscopy revealed that PT apical endocytic apparatus was sig-
nificantly less developed. Immunostaining for megalin
showed a faint signal in PT cytosol contrasting with the dis-
tribution of cubilin at the apical membrane. The diagnostic
procedure led to identifying two mutations of the LRP2 gene.
Conclusions The functional loss of megalin in DB/FOAR
causes PT dysfunction characterized by increased urinary
shedding of CA3 and cubilin.
Keywords Facio-oculo-acoustico-renal syndrome .
Low-molecular-weight proteins . Receptor-mediated
endocytosis .Megalin . Cubilin . Type 3 carbonic anhydrase
Introduction
Plasma albumin and low molecular weight (LMW) proteins
are continuously filtered through renal glomeruli and
reabsorbed by epithelial cells lining the proximal tubules
(PT) via receptor-mediated endocytosis (RME). In PT, RME
implicates the megalin/cubilin/amnionless complex [1].
Megalin is a multi-ligand receptor encoded by the LRP2 gene,
and belongs to the low-density lipoprotein (LDL) receptor
family [2]. Mutations of LRP2 cause autosomal recessive
Donnai–Barrow/facio-oculo-acoustico-renal syndrome (DB/
FOAR), whose cardinal features include: corpus callosum
agenesis, developmental delay, enlarged anterior fontanel,
myopia, hypertelorism, sensorineural hearing loss, and
LMW proteinuria [2, 3]. Megalin-null mice also demonstrate
LMW proteinuria, which emphasizes the role of megalin in
PT RME [4]. Megalin cooperates with another receptor,
named cubilin, which associates with its partner, amnionless
(AMN). At the apical pole of PT epithelial cells, ligand
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binding to the megalin/cubilin/AMN complex induces inter-
nalization into coated vesicles and delivery to endosomes and
lysosomes for ligand processing and receptor degradation or
recycling [5]. Progression along the endocytic apparatus re-
quires vesicular acidification, which is driven by the electro-
genic vacuolar H+-ATPase and a neutralizing Cl− conductance
[6]. The loss of such a Cl− conductance leads to RME dys-
function in PT, like the one observed in Dent's disease [5, 7].
Dent's disease is an X-linked renal tubulopathy characterized
by LMW proteinuria, hypercalciuria, and renal failure. It is
caused by mutations in the CLCN5 gene encoding the Cl−/
H+ exchanger, ClC-5 [5]. Similarly to Dent's disease, genetic
inactivation of Clcn5 in mouse induces a severe trafficking
defect in PTcells, with loss of megalin and cubilin at the brush
border and LMW proteinuria [7]. Furthermore, ClC-5 inacti-
vation causes urinary excretion of type 3 carbonic anhydrase
(CAIII) [8]. CAIII has been uniquely detected in the urine of
ClC-5- or megalin-deficient mice and patients with Dent's
disease. However, data are lacking regarding CAIII excretion
in the urine of megalin-deficient patients. We report on a girl
presenting with typical DB/FOAR. On the basis of a 10-year
follow-up, repeated urine and blood samples, kidney biopsy
materials, and genetic testing, we further characterize the ge-
notype, phenotype, and pathophysiology of this rare entity.
Clinical case
A 3-year-old girl was evaluated for growth retardation and
proteinuria. She was born at 38 gestational weeks. Growth
retardation was initially linked to heavy maternal smoking
during pregnancy. Her parents were non-consanguineous.
Her half-brothers were healthy. Clinical examination was un-
remarkable, except for a still-opened anterior fontanel (which
closed at 4) and bilateral myopia. Psychomotor development
was delayed, which prompted the institutionalization of the
child. At the age of 6, she developed bilateral sensorineural
hearing loss. Hypertelorism was noted when she turned 12.
Blood analyses, including hemoglobin, creatinine, Na+,
Cl-, K+, albumin, uric acid, 25(OH) and 1,25(OH) vitamin D
and thyroid hormones, were within the normal ranges, except
for low levels of transthyretin. Urine sediment was bland.
Heavy proteinuria (1.990 mg/g creatinine) was found, includ-
ing albumin (290 mg/g creatinine) and LMW proteins (α1-
microglobulin, 522 mg/g creatinine; retinol-binding protein
(RBP), 215 mg/g creatinine; neutrophil gelatinase-associated
lipocalin (NGAL), 14 IU/l; transferrin, 55 mg/l; cystatin,
61 mg/l). Immunoblotting analyses also detected cubilin and
CAIII in the urine (Fig. 1a, b). Kidney ultrasound was unre-
markable. A renal biopsy was performed and examined by
both light and electron microscopy. Optical examination did
not disclose any tubular or glomerular abnormality. Electron
microscopy revealed that PT apical endocytic apparatus was
significantly less developed, with a decreased number of coat-
ed pits, early endosomes, and dense apical tubules (Fig. 1c).
Immunostaining for megalin showed a faint and diffuse signal
in PT cells contrasting with the apical distribution of cubilin
(Fig. 1d). CAIII was detected in the cytosol of some PT cells
(Fig. 1d).
The diagnostic procedure led to sequencing the LRP2 gene.
Two mutations were identified: C.7564T > C (p.Y2522H) and
c.12623C > A (p.P4208H). Clinical and genetic testing of the
parents could not be performed for ethical reasons. In the
context of heavy mixed proteinuria, treatment initially includ-
ed angiotensin-converting enzyme inhibitors and indometha-
cin. This treatment had no impact on proteinuria, and was
stopped after a few months. At the age of 12, renal function
of the patient was normal, despite constant proteinuria.
Discussion
The patient presents with most of the cardinal features of
DB/FOAR, including urinary loss of albumin and LMW
Fig. 1 a, b Immunoblotting analyses of urine samples from a patient with
Donnai–Barrow/facio-oculo-acoustico-renal syndrome (DB/FOAR). a
Urinary proteins (equivalent to 10 μg of creatinine in all lanes) of a
healthy control, a patient with DB/FOAR syndrome and a patient with
Dent's disease were separated by SDS-PAGE and visualized after
Coomassie Blue staining. LMWP low molecular weight proteins. b
Similar urinary samples were separated by SDS-PAGE, transferred onto
a nitrocellulose membrane and blotted with antibodies against cubilin
(from Ref. [3]), type 3 carbonic anhydrase (CAIII, from Ref. [8]) or
Tamm-Horsfall protein (UMOD, from Ref. [15]). c Electron
microscopy of renal proximal tubule cells from a patient with DB/
FOAR. Renal tissue samples were collected from the patient for
diagnostic purposes, fixed in glutaraldehyde, and embedded in Epon.
Ultrathin slides were prepared using Leica Reichert Ultracut S, and
visualized on a Zeiss LE0909 electron microscope. The ultrastructure of
PT cells appears normal, except for the apical endocytic apparatus (white
frame). The number of coated pits, early endosomes, and dense apical
tubules is decreased (inset). The brush border looks regular. d
Immunostaining analysis of kidney samples from a patient with DB/
FOAR. Renal tissue samples were fixed in 4% paraformaldehyde and
embedded in paraffin. Serial sections (as notified by the asterisk located
in the same renal tubule) were incubated with primary antibodies against
megalin (from Ref. [3]), aquaporin-1 (from Ref. [15]), cubilin (from Ref.
[3]) or type III carbonic anhydrase (CAIII, from Ref. [8]), followed by
incubation with ad hoc horseradish-conjugated secondary antibodies.
Images were taken using a Leica MC170 HD camera installed on a
Leica DM1000 LED microscope. The typical distribution of megalin,
aquaporin-1, and cubilin at PT brush border (arrowheads) is shown in
the upper panels. In the lower panels, arrowheads indicate the apical
distribution of cubilin at the brush border of proximal tubules (PT),
which are identified by the co-expression of the water channel,
aquaporin-1. Megalin is faintly detected in PT cytosol. CAIII is only
detected in some PT cells (PT+), whereas no signal is detected in others
(PT-). Such a dispersed distribution along the PTwas observed in kidneys
from both ClC-5-deficient mice and patients with Dent's disease [8].
CAIII may participate in PT cell response to oxidative damage
1028 Pediatr Nephrol (2015) 30:1027–1031
Pediatr Nephrol (2015) 30:1027–1031 1029
proteinuria [2]. The amount of physiological glomerular
filtration of albumin remains debated [3]. In mice, PT up-
take of filtered albumin relies on the co-expression of
megalin and cubilin [1]. Consistently, patients with DB/
FOAR show daily albuminuria, l ike in our case
(~250 mg/24 h). Since no PT reabsorption of albumin is
observed in these individuals, physiological albumin filtra-
tion may be extrapolated to the microalbuminuric rather
than nephrotic range. Similarly to previous reports [2, 3],
both megalin ligands, i.e., α1-microglobulin, RBP and
NGAL, and cubilin ligands, i.e., transferrin and cystatin,
are found in our patient’s urine. By immunostaining of
kidney samples, megalin was detectable as a weak and
diffuse signal in PT cytosol, which suggests that C.7564T
> C and c.12623C > A mutations of LRP2 induce a traf-
ficking defect and/or instability of megalin. By contrast,
cubilin distribution was preserved at the PT brush border,
indicating that cubilin processing and targeting are inde-
pendent of megalin function [1]. However, cubilin was also
found in the patient’s urine, in contrast with age- and
gender-matched healthy controls and a patient with Dent's
disease. This supports that, in case of megalin dysfunction,
cubilin is shed into the urine, which in turn leads to urinary
loss of cubilin-specific ligands. Urinalysis also detected
CAIII. In normal physiological conditions, mouse and hu-
man urine is devoid of CAIII. Conversely, its abundance is
significantly augmented in kidney and urine samples from
ClC-5-deficient mice and patients [8]. Here, we show that
CAIII is detectable in kidney and urine samples from a DB/
FOAR patient, which suggests that CAIII may represent a
biomarker of PT dysfunction beyond Dent's disease. As
compared with traditional biomarkers, like α1- and β2-mi-
croglobulin, which are produced outside the kidney, fil-
tered but not reabsorbed because of defective RME, CAIII
in the urine may directly reflect a state of PT cell injury,
without changes in renal function or morphology. Addi-
tional investigations are required to substantiate the rele-
vance of CAIII in other types of inherited or acquired renal
Fanconi syndrome.
The C.7564T > C mutation was described in the orig-
inal report associating DB/FOAR to LRP2 mutations [2].
It concerns an extracellular LDL-receptor class B motif.
The c.12623C > A mutation is novel, and affects a proline
residue located in another extracellular LDL-receptor
class B motif of megalin, with a substitution by histidine.
The proline residue at position 4208 of megalin is highly
conserved throughout evolution, as suggested by compar-
ative sequence alignment using Alamut. The physico-
chemical gap between proline and histidine is significant,
with a Grantham distance of 77. Classical genomic data-
bases, such as Polyphen, predict that c.12623C > A mu-
tation pathologically perturbs pH-dependent ligand/
megalin dissociation in endosomes. Finally, we found an
impaired development of apical endocytic apparatus and a
reduced and mislocalized expression of megalin in PT
cells, which further underscores the pathogeny of both
LRP2 mutations.
Long-term evolution of kidney function in DB/FOAR
patients remains unknown. Twenty-seven cases from 15
families have been reported thus far. Ten reports concern
deceased in utero or neonatal cases. Among the other
cases, two girls developed renal insufficiency at the age
of 18-20 [3, 9]. The rareness of DB/FOAR hampers efforts
to assess long-term prognosis. Also, the variability in phe-
notype severity might be influenced by the type of LRP2
mutations. On a pathophysiological note, a decrease in
megalin membrane expression has been associated with
altered survival in cultured PT cells [10]. Furthermore, dys-
function in PT RME leads to protein overload in the distal
nephron, which mediates inflammation and secretion of
profibrotic factors [11]. Still, the long-term impact on renal
function in the numerous forms of inherited renal Fanconi
syndrome understandably depends on the mutated genes
and implicated pathways.
Besides the kidney, megalin is expressed in many ab-
sorptive epithelia, including the neuro-epithelium. There,
megalin is thought to participate to RME-associated cell
signaling. Failure to uptake ligands at a specific time and/
or in a tissue-specific manner during fetal development
may provoke the various clinical abnormalities observed
in DB/FOAR. Hence, during brain development, megalin
mediates neural tubule specification by acting as a clear-
ance receptor of var ious l igands, such as bone-
morphogenic protein 4, from extra-embryonic fluids [12].
In megalin-deficient mice, impaired ligand uptake by
n e u r o - e p i t h e l i a l c e l l s u l t i m a t e l y l e a d s t o
holoprosencephaly, i.e., fusion of prosencephalic hemi-
spheres. During optic nerve development, megalin modu-
lates sonic hedgehog abundance, thereby favoring the re-
cruitment of oligodendrocyte precursors [13]. In adult
mouse eyes, megalin is expressed in vesicular structures
of the retinal pigment epithelium (RPE) and non-
pigmented ciliary body epithelium. Genetic ablation of
megalin in mouse causes myopia, which is associated with
enlarged RPE melanosomes and abnormal ciliary body de-
velopment [14]. As a whole, these observations further
support that megalin harbors important roles in brain and
eye development and physiology.
In conclusion, the present clinical, biochemical, and ge-
netic investigations of a girl with DB/FOAR provide new
insights into this rare clinical entity and help further under-
stand the pathophysiology of the PT endocytic pathway. It
not only reports on a novel missense mutation of LRP2
gene causing DB/FOAR, but also highlights the role of
megalin in apical RME and cubilin membrane stability in
PT cells.
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